openPR Logo
Press release

GLP 1 Companion Nutrition Market Size to Reach US 18.92 billion by 2035 Driven by Rising Demand for Clinical Nutrition Support - DataM Intelligence

08-05-2026 03:03 PM CET | Food & Beverage

Press release from: DataM intelligence 4 Market Research LLP

GLP 1 Companion Nutrition Market Size

GLP 1 Companion Nutrition Market Size

According to DataM Intelligence, the global GLP 1 companion nutrition market size was valued at US 5.26 billion in 2025 and is projected to reach US 18.92 billion by 2035, expanding at a CAGR of 13.7 percent during the forecast period from 2026 to 2035. The strong outlook reflects increasing demand for specialized nutritional support among individuals using GLP 1 therapies for obesity and type 2 diabetes. The report highlights steady expansion in product innovation, clinical nutrition adoption, and personalized dietary solutions across healthcare and consumer wellness channels.

The market is witnessing a transition from generic high protein supplements to clinically focused nutrition systems that support muscle preservation, digestive health, hydration, and micronutrient intake. Companies are expanding integrated nutrition programs that combine ready to drink products, digital coaching, and dietitian support. Growing partnerships between nutrition companies, telehealth providers, and healthcare professionals continue to shape the GLP-1 companion nutrition market trends, while product development increasingly focuses on compact high protein formulations for users with reduced appetite.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response): https://www.datamintelligence.com/research-report/glp-1-companion-nutrition-market?akash

Recent Developments
· Abbott 2026 Introduced Ensure Strength Pro in India with 30 grams of protein and 31 nutrients to support muscle strength, bone health, immunity, and healthy ageing.

· Wellgistics Health 2026 Launched Forzet, a medical food developed to support nutritional management of muscle loss associated with GLP 1 therapy and weight management treatments.

· Abbott India and Novo Nordisk India 2026 Entered a strategic alliance to launch Extensior Ozempic in India, expanding access to GLP 1 therapies and strengthening demand for companion nutrition products.

Mergers & Acquisitions
· Abbott India and Novo Nordisk India 2026 Formed a strategic collaboration to commercialize Extensior Ozempic in India and strengthen integrated obesity care.

· Wellgistics Health 2026 Expanded its clinical nutrition portfolio through the commercial launch of Forzet to address the nutritional needs of GLP 1 users.

Market Segmentation
By Nutrition Need

· Protein and Lean Mass Support

· HMB Based Formulations

· Digestive Health and Tolerability

· Hydration and Electrolyte Support

· Fiber and Satiety Support

· Hair Skin and Bone Support

· Bone Marrow and Other Organ Support

· Comprehensive GLP 1 Nutrition Systems

By Product Type

· Single GLP 1 Companion Nutrition Products

· Ready to Drink Shakes and Beverages

· Organ Support and Vitamin Mineral Blends

· Softgels and Liquids

· Food Based Formats

By Ingredient Platform

· Dairy and Whey Based

· Plant Based

· Blended Ingredient Platforms

· Precision Fermented and Novel Ingredients

By Consumer Type

· Adults Using GLP 1 Therapy for Obesity

· Adults Using GLP 1 Therapy for Type 2 Diabetes

· Post Bariatric and Medically Managed Weight Loss Users

· Softgels Liquids and Food Based Formats

By Health Objective

· General Wellness

· Energy

· Iron Blood Support

· Sports Recovery

· Healthy Ageing

· Digestive Metabolic

· Other Positioning

By Distribution Channel

· Online DTC

· Specialty Stores

· Pharmacies

· Mass Retail

· Practitioner Channels

Competitive Landscape
The GLP-1 companion nutrition industry is becoming increasingly competitive as established medical nutrition companies, ingredient suppliers, and digital health businesses invest in products tailored for GLP 1 therapy users. Companies are focusing on clinically supported formulations that preserve lean muscle, improve digestive tolerance, and deliver essential nutrients in smaller serving sizes. Innovation is also expanding into integrated care programs that combine nutritional products with personalized coaching and telehealth support, creating stronger customer engagement and recurring revenue opportunities.

The leading companies continue to strengthen their portfolios through product innovation, strategic partnerships, and expanded distribution across pharmacies, online channels, and healthcare providers. Competitive differentiation depends on scientific validation, ingredient quality, transparent labeling, and convenience for long term users.

Top 5 Key Players
· Nestlé Health Science

· Abbott Nutrition

· Roquette

· Glanbia

· Heart and Soil

Speak to Our Analyst and Get Customization in the Report as per Your Requirements: https://www.datamintelligence.com/customize/glp-1-companion-nutrition-market?akash

Regional Analysis Europe
Europe accounted for approximately 24.3 percent of the GLP-1 companion nutrition market share in 2025 and continues to represent an established regional market throughout the forecast period. The region benefits from strong clinical nutrition adoption, well developed pharmacy networks, and high consumer confidence in premium nutritional products. Strict regulatory standards have encouraged manufacturers to prioritize quality assurance, ingredient transparency, and evidence based product positioning.

Demand across Europe is supported by increasing awareness of muscle preservation, balanced nutrition, and digestive health among individuals receiving GLP 1 therapies. Expanding clinical nutrition programs, specialty wellness retailers, and healthcare practitioner recommendations continue to support the GLP-1 companion nutrition market growth. As companies introduce innovative formulations designed for improved nutrient density and digestive tolerance, Europe is expected to maintain steady expansion while remaining an important contributor to the global market.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=glp-1-companion-nutrition-market?akash

Conclusion
The GLP-1 companion nutrition market is entering a new phase of development as nutritional support becomes an essential component of obesity and diabetes care. Growing awareness of muscle preservation, hydration, digestive health, and micronutrient balance is driving demand for specialized companion nutrition products that complement GLP 1 therapies. Continued investment in clinical research, product innovation, and integrated healthcare partnerships is expected to strengthen long term commercial opportunities.

With expanding adoption across healthcare providers, telehealth platforms, and consumer wellness channels, the market size is expected to rise steadily over the coming decade. Industry participants that focus on scientific validation, personalized nutrition, and convenient product formats will be well positioned to benefit from the GLP-1 companion nutrition market forecast while strengthening their position in an increasingly competitive global marketplace.

Industry Related Reports:

Menopause Supplements Market Size:
The global menopause supplements market was valued at US$ 985.81 million in 2025 and is projected to reach US 1,713.99 million by 2035, growing at a CAGR of 5.7% during 2026-2035. Rising demand for holistic solutions supporting sleep, mood, bone health, metabolism, and healthy aging is driving market growth.

Get More Views: https://www.datamintelligence.com/research-report/menopause-supplements-market?akash

Men's Health Supplements Market Forecast:
The men's health supplements market covers products such as vitamins, minerals, proteins, botanicals, probiotics, and specialty nutrients. The market is segmented by product type, health benefit, ingredient, dosage form, age group, distribution channel, and regions including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

Get More Views: https://www.datamintelligence.com/research-report/mens-health-supplements-market?akash

Explore more Japan reports: https://www.datamintelligence.com/jp-market-research-report?akash

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GLP 1 Companion Nutrition Market Size to Reach US 18.92 billion by 2035 Driven by Rising Demand for Clinical Nutrition Support - DataM Intelligence here

News-ID: 4596259 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Cryogenic Electronics Market Size to Reach USD 5.56 Billion by 2035, Driven by Quantum Computing Advancements - DataM Intelligence
Cryogenic Electronics Market Size to Reach USD 5.56 Billion by 2035, Driven by Q …
According to Data Intelligence, the cryogenic electronics market size reached USD 1.35 billion in 2025 and is projected to reach USD 5.56 billion by 2035, expanding at a CAGR of 15.2% during the forecast period 2026-2035. The increasing commercialization of quantum technologies, rising investments in superconducting systems, and continuous innovation in ultra-low-temperature electronic components are creating strong opportunities across research laboratories, healthcare, aerospace, and high-performance computing applications. The cryogenic electronics market
Discrete Semiconductors Market Reindustrializes Around Silicon Carbide as Governments Target Power-Electronics Supply-Chain Bottlenecks
Discrete Semiconductors Market Reindustrializes Around Silicon Carbide as Govern …
NEW YORK, July 31, 2026 - The global Discrete Semiconductors Market reached US$ 49.97 billion in 2025 and is expected to reach US$ 175.64 billion by 2035, growing at a CAGR of 14.2% during the forecast period 2026-2035, according to DataM Intelligence. The market is gaining strategic importance as governments and manufacturers seek greater control over the semiconductor devices responsible for switching, regulating and converting electrical power. Unlike the race for
Solid-State Cooling Market Breaks Out of Consumer Electronics as AI Optics, HBM and Fanless Computing Create New Thermal Architectures
Solid-State Cooling Market Breaks Out of Consumer Electronics as AI Optics, HBM …
NEW YORK, July 31, 2026 - The global Solid-State Cooling Market is gaining a larger role in electronics and digital infrastructure as higher chip densities create concentrated thermal problems that cannot always be solved by increasing fan speed or facility-level cooling. According to DataM Intelligence, the market was valued at US$0.96 billion in 2025 and is projected to reach US$2.08 billion by 2033, expanding at a CAGR of 10% during
Bioelectric Medicine Market Widens Beyond Chronic Pain as Wearable Neurostimulation Platforms Target Stress, Hemorrhage and Addiction Care
Bioelectric Medicine Market Widens Beyond Chronic Pain as Wearable Neurostimulat …
NEW YORK, July 31, 2026 - The global bioelectric medicine market reached US$31.34 billion in 2024 and is projected to reach US$235.55 billion by 2033, growing at a compound annual growth rate of 22.3% between 2025 and 2033, according to DataM Intelligence. Much of that growth reflects one engineering choice: rather than a separate device per condition, manufacturers are designing one stimulation platform reprogrammable across multiple clinical uses. That approach

All 5 Releases


More Releases for GLP

GLP-1 SuperDefender: The Revolutionary Oral Protection Appliance Against "Ozempi …
Los Angeles, California - Feb 18, 2026 - As medications like Ozempic Registered , Wegovy Registered , and Mounjaro Registered continue to reshape the future of weight management and diabetes treatment, millions of patients are unknowingly facing a growing dental crisis. Reports of acid reflux, dry mouth, and teeth grinding are rising among GLP-1 medication users, leading to irreversible enamel erosion and tooth loss; Collectively known as "Ozempic Teeth". In response
American Made GLP-1 Names CoreAge Rx As Best GLP-1 Provider for 2026
Image: https://www.abnewswire.com/upload/2026/02/8efbd0ec583b0fd3f145d91eb24f2e05.jpg American Made GLP-1, a US- based healthcare resource dedicated to reviewing and comparing GLP-1 treatment providers, has released its latest rankings of telehealth platforms offering physician-supervised GLP-1 programs for weight management, naming CoreAge Rx as the #1 GLP-1 Provider and awarding the platform an outstanding 4.9 out of 5 rating. The independent review evaluated more than 10 U.S.-based telehealth providers and recognized CoreAge Rx with the designation "Editor's Choice,"
GLP Diet Review: Tailored Nutrition and Support for GLP-1 Users
Image: https://www.globalnewslines.com/uploads/2026/01/1768225059.jpg GLP Diet Review - A Personalized GLP-1 Diet The GLP Diet [https://glp.diet/?utm_source=abnewswire&utm_medium=organic&utm_campaign=bio] is a personalized wellness program designed to help users maximize the benefits of their GLP-1 weight loss medications. It offers tailored meal plans, balanced recipes, guided workouts, lifestyle challenges, and practical tools for tracking progress. Built around each user's unique needs, it turns complex nutrition advice into clear daily actions that support weight loss, better health, and long-term
12-17-2025 | Sports
ABNewswire
Alpharetta Medical Clinic Earns Top Recognition for Excellence in Peptide, GLP-1 …
Dr. Weight Loss of Atlanta in Alpharetta is proud to announce its recognition as the top-rated provider of medical weight loss and peptide therapy services in the Alpharetta area. This distinction reflects the clinic's sustained commitment to clinical excellence, patient-centered care, and successful treatment outcomes in the field of metabolic health. Alpharetta, GA - December 16, 2025 - Dr. Weight Loss of Atlanta [https://drweightlossofatlanta.com/peptide-therapy-alpharetta] in Alpharetta is proud to announce its
12-17-2025 | Sports
ABNewswire
Medical Clinic Recognized as Top Peptide, GLP-1, & GLP-3 Therapies in Sandy Spri …
Dr. Weight Loss of Atlanta announced today that its Sandy Springs location has earned recognition as a leading medical weight loss and peptide therapy clinic in Sandy Springs, reflecting exceptional patient satisfaction, consistently strong clinical outcomes, and a reputation for delivering personalized, expert-guided care. Sandy Springs, GA - December 16, 2025 - Dr. Weight Loss of Atlanta [https://drweightlossofatlanta.com/peptides-sandy-springs] announced today that its Sandy Springs location has earned recognition as a leading
11-24-2025 | Health & Medicine
Glp1-pr
My Start GLP 1 Reviews: The GLP 1 That is Changing the Way America loss Weight
In the modern era of health innovation, few breakthroughs have generated as much excitement as My Start GLP 1. In 2025, it has rapidly become one of the most talked-about doctor-supervised weight loss programs in the United States. With thousands of verified patient success stories, My Start GLP 1 has positioned itself as more than a trend-it is a science-backed revolution changing how we understand metabolism, hunger, and sustainable fat